[Pharmacokinetics of dextromoramide in the surgical patient].
The pharmacokinetics of dextromoramide were studied in nine patients undergoing peripheral vascular surgery. All the patients were anaesthetised with thiopentone and vecuronium. After tracheal intubation, anaesthesia was maintained with 0.5 to 1.5 vol % halothane and a 60%-40% vol nitrous oxide-oxygen mixture. Once the patient's status was stable, a 0.8 mg.kg-1 bolus of dextromoramide was given intravenously. Blood samples were obtained 2, 5, 10, 30, 60, 90, 120, 180, 240, 300, 360, and 420 min afterwards by an arterial catheter. Dextromoramide serum concentrations were measured with high performance liquid chromatography after extraction with an original technique. The pharmacokinetic parameters were calculated by computer using TRIOMPHE. In five patients, a bi-exponential equation best fitted the results, whereas a tri-exponential equation was necessary for the other four. Mean elimination half-life was 215.3 +/- 78.4 min, and the apparent final volume of distribution was 0.58 +/- 0.20 l.kg-1. Hepatic extraction was low, as shown by a mean systemic clearance of 2.0 +/- 0.9 ml.kg-1.min-1. Liposolubility of this drug is the highest of all opiates, with a heptane/water partition coefficient of 12.3. These parameters demonstrate that, in the opiate drug group, dextromoramide has a place apart from the others.
Lançon
J P
JP
Département d'Anesthésie-Réanimation, Hôpital du Bocage, Dijon.
Pechinot
A
A
Athis
P D
PD
Pechinot
M
M
Pointaire
P
P
Obadia
J F
JF
Caillard
B
B
D000368:Aged; D000701:Analgesics, Opioid / Q000493:pharmacokinetics; D000768:Anesthesia, General; D003916:Dextromoramide / Q000097:blood / Q000493:pharmacokinetics*; D006801:Humans; D008875:Middle Aged; D014656:Vascular Surgical Procedures
D000701:Analgesics, Opioid; D003916:Dextromoramide
Pharmacocinétique du dextromoramide chez l'opéré.